Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3787319
Max Phase: Preclinical
Molecular Formula: C23H22N2O
Molecular Weight: 342.44
Molecule Type: Small molecule
Associated Items:
ID: ALA3787319
Max Phase: Preclinical
Molecular Formula: C23H22N2O
Molecular Weight: 342.44
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: c1ccc(Oc2ccc(CNCCc3c[nH]c4ccccc34)cc2)cc1
Standard InChI: InChI=1S/C23H22N2O/c1-2-6-20(7-3-1)26-21-12-10-18(11-13-21)16-24-15-14-19-17-25-23-9-5-4-8-22(19)23/h1-13,17,24-25H,14-16H2
Standard InChI Key: NTJSXZMZJOFXBE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 342.44 | Molecular Weight (Monoisotopic): 342.1732 | AlogP: 5.29 | #Rotatable Bonds: 7 |
Polar Surface Area: 37.05 | Molecular Species: BASE | HBA: 2 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 9.62 | CX LogP: 5.14 | CX LogD: 2.96 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.45 | Np Likeness Score: -0.57 |
1. Bertamino A, Ostacolo C, Ambrosino P, Musella S, Di Sarno V, Ciaglia T, Soldovieri MV, Iraci N, Fernandez Carvajal A, de la Torre-Martinez R, Ferrer-Montiel A, Gonzalez Muniz R, Novellino E, Taglialatela M, Campiglia P, Gomez-Monterrey I.. (2016) Tryptamine-Based Derivatives as Transient Receptor Potential Melastatin Type 8 (TRPM8) Channel Modulators., 59 (5): [PMID:26847872] [10.1021/acs.jmedchem.5b01914] |
2. Pandolfi F, D'Acierno F, Bortolami M, De Vita D, Gallo F, De Meo A, Di Santo R, Costi R, Simonetti G, Scipione L.. (2019) Searching for new agents active against Candida albicans biofilm: A series of indole derivatives, design, synthesis and biological evaluation., 165 [PMID:30660829] [10.1016/j.ejmech.2019.01.012] |
Source(1):